On the other hand, multiple B-cell cancers, such as chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), diffuse large B-cell lymphoma (DLBCL), and acute myeloid leukemia (AML), are linked with the upregulation of BTK [13,46]. This evidence concerns the gene BTK and B-cell chronic lymphocytic leukemia.